Ampio Pharmaceuticals, Inc. (AMPE) Q1 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you, and welcome to the NPO Pharmaceuticals first quarter 2021 earnings result and business update webinar. As a reminder, this call is being recorded, and listeners will be on a listen-only mode. If you would like to ask a question, please dial star 1 on your telephone keypad. If you are accessing this call by webinar, you may submit your questions online in the ask a question portion of your screen. At this time, I would like to turn the call over to Mr. Dan Stokely, CFO. Dan, please. Yeah, thank you very much. And I hope everyone's having a great day. It's our pleasure, me and the rest of the MPO executive management team to be present today. And we'd like to thank each one of you for attending our first quarter 2021 financial results and business update call, either via phone or the webcast. Prior to reading the Safe Harbor forward-looking statement, I'd like to introduce you to the members of the executive management team of Ampio Pharmaceuticals, who will be both presenting and participating on the call today. First here with us at the company headquarters in Englewood, Colorado, is Mr. Mike Macaluso, the Chairman and Chief Executive Officer. We also have present Dr. David Baror, Director and Founder, Holly Cherevka, the company's Chief Operating Officer, and me, Dan Stokely, the Chief Financial Officer. I'd like to start out by first reading our safe harbor statement. These slides and materials, including any company and oral presentation, may contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements as these statements are based upon our current expectations, forecasts, and assumptions and are subject to significant risks and uncertainties. These statements may be identified by words such as...